THAR logo

Tharimmune (THAR) Company Overview

Profile

Full Name:

Tharimmune, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 12, 2022

Indexes:

Not included

Description:

THAR (Tharimmune) is a biotechnology company focused on developing innovative therapies for autoimmune diseases. They aim to create effective treatments that improve patients' lives by targeting the underlying causes of these conditions. Their research combines advanced science with a commitment to patient care and health improvement.

Events Calendar

Earnings

Next earnings date:

May 9, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

May 28, 2024

Analyst ratings

Recent major analysts updates

Dec 6, 24 Rodman & Renshaw
Buy
Jul 17, 23 Dawson James
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Tharimmune?
  • Does Tharimmune pay dividends?
  • What sector is Tharimmune in?
  • What industry is Tharimmune in?
  • What country is Tharimmune based in?
  • When did Tharimmune go public?
  • Is Tharimmune in the S&P 500?
  • Is Tharimmune in the NASDAQ 100?
  • Is Tharimmune in the Dow Jones?
  • When was Tharimmune's last earnings report?
  • When does Tharimmune report earnings?
  • Should I buy Tharimmune stock now?

What is the ticker symbol for Tharimmune?

The ticker symbol for Tharimmune is NASDAQ:THAR

Does Tharimmune pay dividends?

No, Tharimmune does not pay dividends

What sector is Tharimmune in?

Tharimmune is in the Healthcare sector

What industry is Tharimmune in?

Tharimmune is in the Biotechnology industry

What country is Tharimmune based in?

Tharimmune is headquartered in United States

When did Tharimmune go public?

Tharimmune's initial public offering (IPO) was on January 12, 2022

Is Tharimmune in the S&P 500?

No, Tharimmune is not included in the S&P 500 index

Is Tharimmune in the NASDAQ 100?

No, Tharimmune is not included in the NASDAQ 100 index

Is Tharimmune in the Dow Jones?

No, Tharimmune is not included in the Dow Jones index

When was Tharimmune's last earnings report?

Tharimmune's most recent earnings report was on Nov 7, 2024

When does Tharimmune report earnings?

The next expected earnings date for Tharimmune is May 9, 2025

Should I buy Tharimmune stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions